Immunology Assays
A comprehensive in vitro platform to accelerate cancer immunotherapy drug discovery:
- Binding & blocking assessment (via biophysical and biochemical assays, and flow cytometry)
- Immune cell activation (T cell, B cell, and NK cells)
- Immune cell suppression (MDSC and Treg suppressive assays)
- Immune T cell polarization and macrophage differentiation
- Antigen presentation/mixed lymphocyte reaction (including mouse allogenic splenocytes, DC co-cultures with T cells )
- in vitro cytotoxicity assay (including ADCC, ADCP, and CDC)
Check out our comprehensive platform of immunology services
Immunology Services Platform
Related Content
Strategies to stimulate dendritic cell (DC) activity, such as ex vivo generation and priming of DC vaccines, have been explored...
VIEW RESOURCENatural killer (NK) cells play a crucial role in the immune system and can recognize and kill cancer cells. Research...
VIEW RESOURCE